$8.050
-0.020 (-0.25%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BCRX Prediction & Forecast by Similar Chart Analysis
Alphio's BCRX stock price prediction model matches the current BioCryst Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.97 (-0.58%). The 1-week path is $8.06 (+0.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy BioCryst Pharmaceuticals, Inc. Stock?
BioCryst Pharmaceuticals Inc (BCRX) appears to be a good buy at the current price of $8.55, especially considering its recent revenue growth and positive market sentiment. The company's gross margin stands at an impressive 98.24% for Q2 2026, indicating strong profitability potential. Additionally, the stock has shown a 14% year-to-date increase, reflecting positive investor interest. However, a key risk is the recent downgrade by RBC, which lowered the price target to $11 due to competitive pressures, suggesting potential limited upside in the near term.
BCRX stock price ended at $8.05 on Wednesday, after losing -0.25%
BioCryst Pharmaceuticals, Inc. (BCRX) last closed at $8.02, losing -0.37%. These facts feed the 1-day and 1-week BCRX price prediction above.
Forecast Drivers
BioCryst Pharmaceuticals, Inc. (BCRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BCRX, ranked by similarity.
Seasonality analysis for BCRX
Historically the probability of a positive October return for BCRX is 59.65%. July offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BCRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $16.05 | $16.54 | $19.80 | +106.25% |
| Nov 2026 | $12.53 | $14.03 | $16.10 | +74.95% |
| Dec 2026 | $15.40 | $17.17 | $18.22 | +114.07% |
In 2026, BioCryst Pharmaceuticals, Inc. (BCRX) is projected to range from $12.53 to $19.80.
BioCryst Pharmaceuticals, Inc. 2026 monthly forecast
In Oct 2026, BioCryst Pharmaceuticals, Inc. is projected to average $16.54, with a low of $16.05 and high of $19.80.
In Nov 2026, BioCryst Pharmaceuticals, Inc. is projected to average $14.03, with a low of $12.53 and high of $16.10.
In Dec 2026, BioCryst Pharmaceuticals, Inc. is projected to average $17.17, with a low of $15.40 and high of $18.22.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.